OxThera

OxThera

OxThera

OxThera develops products for the treatment of metabolic disorders resultingfrom excess levels of oxalate.
Raised
$88.5M
Follow us
Alexa global traffic share
29 Nov 2016
€32,000,000
Venture capital

OxThera Raises €32M in Funding

FinSMEs
+1
16 Apr 2014
$10,521,261
Undisclosed funding
29 Jun 2007
$21,894,082
Undisclosed funding
11 Jul 2005
$20,908,870
Venture capital